Information about the Pfizer-BioNTech COVID-19 vaccine

National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases.

i

Information about the Pfizer-BioNTech COVID-19 vaccine

Supporting Files Public Domain

Dec. 22, 2020
By National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases.

File Language:

English

Details

Corporate Authors:

National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases.
Description:

Updated Dec. 22, 2020

Name: BNT162b2

Manufacturer: Pfizer, Inc., and BioNTech

Type of vaccine: mRNA

mRNA vaccines are a new type of vaccine to protect against infectious diseases. These vaccines teach our cells how to make a protein—or even just a piece of a protein—that triggers an immune response inside our bodies. This immune response, which includes making antibodies, protects us from getting infected if the real virus enters our bodies.

Number of shots: 2 shots, 21 days apart

How given: Shot in the muscle of the upper arm
Subjects:
Document Type:

Webpage
Corporate as Subject:

Pfizer-BioNTech COVID-19 Vaccine ; Pfizer-BioNTech COVID-19 Vaccine
Download URL:

https://stacks.cdc.gov/view/cdc/99347/cdc_99347_DS1.pdf
File Type:

[PDF - 115.73 KB]
Collection(s):

Stephen B. Thacker CDC Library
Main Document Checksum:

urn:sha256:26f0374df5e6cbeb9f1fac6970b56abc532fea6ee715030668a418ce518f3f17

Pfizer-BioNTech.html

html

File Language:

English

ON THIS PAGE

Details Supporting Files

Was this page helpful?

Found an issue?

Send us an email at:

publishinghd@cdc.gov

CDC STACKS serves as an archival repository of CDC-published products including scientific findings, journal articles, guidelines, recommendations, or other public health information authored or co-authored by CDC or funded partners.

As a repository, CDC STACKS retains documents in their original published format to ensure public access to scientific information.